| 11/23/2022 |
3174B Nitrate/Nitrite (Qualitative), Blood (Forensic) |
| 11/23/2022 |
3174SP Nitrate/Nitrite (Qualitative), Serum/Plasma |
| 11/21/2022 |
3428SP PFASure TM, Serum/Plasma |
| 11/9/2022 |
2482FL Ketorolac, Vitreous Fluid (Previously: Special Request) |
| 11/8/2022 |
4120B 4120B |
| 11/8/2022 |
4120U Ropivacaine, Urine |
| 11/8/2022 |
4215B Strychnine, Blood |
| 11/8/2022 |
4215FL Strychnine, Fluid |
| 11/8/2022 |
4215SP Strychnine, Serum/Plasma |
| 11/8/2022 |
4215TI Strychnine, Tissue |
| 11/8/2022 |
4215U Strychnine, Urine |
| 9/16/2022 |
1481B Deschloroetizolam, Meclonazepam, and Pyrazolam, Blood |
| 9/16/2022 |
1481SP Deschloroetizolam, Meclonazepam, and Pyrazolam, Serum/Plasma |
| 9/16/2022 |
1481U Deschloroetizolam, Meclonazepam, and Pyrazolam (Qualitative), Urine |
| 9/13/2022 |
8031U Child Drug Exposure Screen, Urine |
| 8/23/2022 |
8064B Postmortem BHB and Alcohol Profile, Blood (Forensic) |
| 7/9/2022 |
2185TI Guaifenesin, Tissue (Previously: Special Request) |
| 7/9/2022 |
2390TI Ibuprofen, Tissue (Previously: Special Request) |
| 7/9/2022 |
3063B Mycophenolic Acid and Metabolite, Blood (Previously: Special Request) |
| 7/9/2022 |
3063U Mycophenolic Acid and Metabolite, Urine (Previously: Special Request) |
| 5/19/2022 |
2041U Flunitrazepam and Metabolites, Urine |
| 5/4/2022 |
4312U Tapentadol - Total, Urine |
| 4/28/2022 |
1029SP CBD, Serum/Plasma |
| 4/8/2022 |
1320TI Colchicine, Tissue (Previously: Special Request) |
| 4/6/2022 |
0801ME Buprenorphine and Metabolite - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
| 3/31/2022 |
0308SP Amisulpride, Serum/Plasma |
| 3/29/2022 |
4783B Voclosporin, Blood |
| 3/17/2022 |
2745B Methane, Blood |
| 12/1/2022 |
0718B Brivaracetam, Blood |
| |
8054B Postmortem, Expanded w/NPS, Blood (Forensic) |
| |
2533SP Loperamide and Metabolite, S/P |
| |
2533B Loperamide and Metabolite, Blood |
| |
9145UC Comprehensive Drug Screen, Umbilical Cord Tissue |
| |
2457SP Isavuconazole, Serum/Plasma |
| |
0939B Calcium - Total, Blood (Forensic) |
| |
6604S Borrelia burgdorferi total Ab by ELISA with reflex to IgG and IgM by Western Blot (Early Disease) |
| |
6605S Borrelia burgdorferi total Ab by ELISA with reflex to IgG by Western Blot (Late Disease) |
| |
6603S Borrelia burgdorferi Antibody, IgG and IgM by Western Blot, Serum |
| |
6602S Borrelia burgdorferi Antibody, IgM by Western Blot, Serum |
| |
6601S Borrelia burgdorferi Antibody, IgG by Western Blot, Serum |
| |
6600S Borrelia burgdorferi Antibodies, Total by ELISA, Serum |
| |
7177SL Quantitation of THC, THCA, CBD and CBN in Botanical Material by HPLC-DAD, Solid |
| |
9206U Dextrorphan / Levorphanol Screen - Total, U |
| |
4127ME Suboxone® - Total (Qualitative), Meconium |
| |
4236B Suvorexant, Blood |
| |
4236SP Suvorexant, Serum/Plasma |
| |
2500SP Leptin, Serum/Plasma |
| |
1021U Substituted Cathinone Panel, Urine |
| |
1021B Substituted Cathinone Panel, Blood |
| |
1021SP Substituted Cathinone Panel, S/P |
| |
3371SP PCB Panel, Congeners, Serum/Plasma |
| |
7659SP Cortisol and Cortisone, Serum/Plasma |
| |
7658SP Cortisone, Serum/Plasma |
| |
8210B Novel Psychoactive Substances Expanded |
| |
8210U Novel Psychoactive Substances Expanded |
| |
8210SP Novel Psychoactive Substances Expanded |
| |
1485SP Designer Opioids, Serum/Plasma |
| |
1485B Designer Opioids, Blood |
| |
4489SP Tofacitinib, Serum/Plasma |
| |
4489B Tofacitinib, Blood |
| |
4102B Rosiglitazone, Blood |
| |
4101SP Repaglinide, Serum/Plasma |
| |
4102SP Rosiglitazone, Serum/Plasma |
| |
3779SP Pioglitazone, Serum/Plasma |
| |
4101B Repaglinide, Blood |
| |
3118SP Nateglinide, Serum/Plasma |
| |
3118B Nateglinide, Blood |
| |
3779B Pioglitazone, Blood |
| |
2159B Glimepiride, Blood |
| |
2159SP Glimepiride, Serum/Plasma |
| |
3325B Paraquat, Blood |
| |
1789SP Diquat, Serum/Plasma |
| |
1789B Diquat, Blood |
| |
7365SL DNA Analysis, Data Pack |
| |
7679S Dihydrotestosterone (DHT), Serum |
| |
7311SL DNA Analysis, RapidHIT GlobalFiler Express |
| |
0430U Aromatic Solvents Metabolites Panel 2, Urine |
| |
1876FL Drug Screen - Expanded, Fluid |
| |
1876SP Drug Screen - Expanded, Serum/Plasma |
| |
7361SL Legal Paternity Testing (STR Analysis) |
| |
7360SL DNA Analysis, Y-STR (Databasing/Property Crime) |
| |
7359 DNA Analysis, Autosomal STR (Databasing/Property Crime) |
| |
7358SL Kinship Analysis (STR Analysis |
| |
7356SL DNA Analysis, Minifiler (Casework |
| |
7357SL DNA Analysis, Y-STR (Reference) |
| |
8150B ProofPOSITIVE® Drug Impaired Driving/DRE Toxicology Panel |
| |
8151B ProofPOSITIVE® Drug Impaired Driving/DRE ToxicologyPanel (with Alcohol) |
| |
4047SP Pyrrolidinophenone Panel, Serum/Plasma |
| |
4047B Pyrrolidinophenone Panel, Blood |
| |
4046SP Pyrrolidinophenone Panel (Qualitative), S/P |
| |
4046B Pyrrolidinophenone Panel (Qualitative), Bld |
| |
7678P Plasma Renin Activity, Plasma |
| |
7679S Dihydrotestosterone (DHT), Serum |
| |
2428SP Iodine, Serum/Plasma |
| |
2428U Iodine - Total, Urine |
| |
4791SP Vortioxetine, Serum/Plasma |
| |
3143SP NBOMe (Qualitative), Serum/Plasma |
| |
3143B NBOMe (Qualitative), Blood |
| |
4366 Teriflunomide (Therapeutic Drug Monitoring) |
| |
4367 Teriflunomide (Pre-Pregnancy Monitoring) |
| |
2532 Leflunomide as Metabolite (Pre-Pregnancy Monitoring) |
| |
2531 Leflunomide as Metabolite (Therapeutic Drug Monitoring) |
| |
3143U NBOMe (Qualitative), Urine |
| |
7677P Catecholamines, Fractionated & Free |
| |
7676P Norepinephrine - Free, Plasma |
| |
7674P Dopamine - Free, Plasma |
| |
7673P Catecholamines, Fractionated & Free |
| |
7675P Epinephrine - Free, Plasma |
| |
0775B Budesonide, Serum/Plasma |
| |
1290UH Cobalt, 24 Hour Urine |
| |
9190FL Ketoacidosis Screen, Fluid |
| |
9190B Ketoacidosis Screen, Blood |
| |
7079B Oxycodone Metabolizer Status, Blood |
| |
7078B Tramadol Metabolizer Status, Blood |
| |
7077B Codeine Metabolizer Status, Blood |
| |
2665B Mercaptopurine and Metabolites, Blood |
| |
9568U Synthetic Cannabinoid Metabolites Screen 2, Urine |
| |
4519TI Topiramate, Tissue |
| |
4519FL Topiramate, Fluid |
| |
4125B Rufinamide, Blood |
| |
2022SP Eplerenone, Serum/Plasma |
| |
0205U Acetyl Fentanyl, Urine |
| |
0205SP Acetyl Fentanyl, Serum/Plasma |
| |
8088B Qsymia®, Blood |
| |
0205B Acetyl Fentanyl, Blood |
| |
8088SP Qsymia®, Serum/Plasma |
| |
9105SP Acetyl Fentanyl Screen, Serum/Plasma |
| |
9105U Acetyl Fentanyl Screen, Urine |
| |
9105B Acetyl Fentanyl Screen, Blood |
| |
0505SP Bedaquiline, Serum/Plasma |
| |
9005OF Drug Impaired Driving/DRE Toxicology Panel (Qualitative), Oral Fluid |
| |
0245U Alpha PVP, Urine |
| |
0245SP Alpha PVP, Serum/Plasma |
| |
0245B Alpha PVP, Blood |
| |
4114SP Rivaroxaban, Serum/Plasma |
| |
0448SP Apixaban, Serum/Plasma |
| |
0078SP 5-Fluorouracil and Metabolite, S/P |
| |
0110SP 1,25-Dihydroxyvitamin D, Serum/Plasma |
| |
3135SP Vitamin K, Serum/Plasma |
| |
1495SP Desomorphine, Serum/Plasma |
| |
1515B Diazoxide, Blood |
| |
2345B Hydroflumethiazide, Blood |
| |
1495B Desomorphine, Blood |
| |
0495SP Avanafil, Serum/Plasma |
| |
0495B Avanafil, Blood |
| |
0420FL Betahydroxybutyric Acid, Fluid |
| |
0420B Betahydroxybutyric Acid, Blood |
| |
4525B Torsemide, Blood |
| |
4525SP Torsemide, Serum/Plasma |
| |
4624U Trichloroacetic Acid, Urine |
| |
2397SP Indapamide, Serum/Plasma |
| |
3433SP Perampanel, Serum/Plasma |
| |
9318U Diuretics Screen, Urine |
| |
9235SP Phenazepam Screen (Qualitative), S/P |
| |
9235U Phenazepam Screen (Qualitative), Urine |
| |
9229SP DMAA Screen, Serum/Plasma |
| |
9235B Phenazepam Screen (Qualitative), Blood |
| |
9229B DMAA Screen, Blood |
| |
9229U DMAA Screen, Urine |
| |
0278B DMAA, Blood |
| |
0278SP DMAA, Serum/Plasma |
| |
0278U DMAA, Urine |
| |
4365SP Teriflunomide, Serum/Plasma |
| |
4365U Teriflunomide, Urine |
| |
4365B Teriflunomide, Blood |
| |
4029SP Psilocybin as Psilocin (Qualitative), S/P |
| |
4029U Psilocybin as Psilocin (Qualitative), Urine |
| |
4029B Psilocybin as Psilocin (Qualitative), Blood |
| |
9570U Tapentadol Screen, Urine |
| |
8898OF Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid |
| |
8085U Drug Impaired Driving/DRE Bath Salts Add-On, Urine |
| |
8085SP Drug Impaired Driving/DRE Bath Salts Add-On, S/P |
| |
8065TI Bath Salts Screen (Forensic), Tissue |
| |
8085B Drug Impaired Driving/DRE Bath Salts Add-On, Blood |
| |
8065FL Bath Salts Screen (Forensic), Fluid |
| |
8065SP Bath Salts Screen (Forensic), Serum/Plasma |
| |
8065U Bath Salts Screen (Forensic), Urine |
| |
8065B Bath Salts Screen (Forensic), Blood |
| |
2626SP Bath Salts Panel, Serum/Plasma |
| |
2626B Bath Salts Panel, Blood |
| |
7308SL DNA Analysis, Full Profile (Reference) |
| |
1876U Drug Screen, Expanded, Urine |
| |
1876B Drug Screen, Expanded, Blood |
| |
1874U Drug Screen (9 Panel), Urine |
| |
1874B Drug Screen (9 Panel), Blood |
| |
2092B Fluoride Preservative Determination, Blood |
| |
1935SP Exemestane, Serum/Plasma |
| |
9567OF Synthetic Cannabinoids (qualitative), Oral Fluid |
| |
4025SP Ezogabine and Metabolite, Serum/Plasma |
| |
2478U Zolpidem and Metabolites, Urine |
| |
9564U Synthetic Cannabinoid Metabolites Screen - Basic |
| |
4155B Sativex®, Blood |
| |
4155SP Sativex®, Serum/Plasma |
| |
1902SP Duexis®, Serum/Plasma |
| |
1902B Duexis®, Blood |
| |
2527FL Lacosamide, Fluid |
| |
2479U Ketamine and Metabolite, Urine |
| |
8061TI Postmortem Toxicology-Basic, w/o Alcohol, Tissue |
| |
8756SP Bath Salts & Stimulants Designer Drugs-Expanded |
| |
8756U Bath Salts & Stimulants Designer Drugs-Expanded |
| |
8756B Bath Salts & Stimulants Designer Drugs-Expanded |
| |
3078U Mitragynine and Metabolite (Qualitative), Urine |
| |
1348FL Creatinine (Vitreous), Fluid (Forensic) |
| |
7309SL Post-PCR Cleanup Analysis |
| |
0751SP Bromocriptine, Serum/Plasma |